日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Rare Case of Primary Ovarian Mucinous Carcinoma with Signet-Ring Cells and Literature Review

一例罕见的伴有印戒细胞的原发性卵巢黏液性癌病例报告及文献复习

Gundogdu, Fatma; Usubutun, Alp

Impact of Adipokine Expression on Tumor Characteristics and Survival Outcomes in Patients with Renal Cell Carcinoma.

脂肪因子表达对肾细胞癌患者肿瘤特征和生存结果的影响。

Aktepe Oktay Halit, Ulasli Tugce, Terzi Aytac, Gundogdu Fatma, Caliskan Yildirim Eda, Arslan Ahmet Melih, Semiz Huseyin Salih, Kosemehmetoglu Kemal, Karaoglu Aziz, Erman Mustafa, Yalcin Suayib

Breakthrough cancer pain: assessment and self-management perspectives among oncology nurses

突破性进展:肿瘤科护士对癌症疼痛的评估和自我管理视角

Duzova, Ulku Saygili; Kilic, Mustafa; Gundogdu, Fatma; Yildirim, Dilek; Can, Gulbeyaz; Talu, Gul Koknel

Reliability assessment of methylthioadenosine phosphorylase immunohistochemistry as a surrogate biomarker for CDKN2A homozygous deletion in adult-type IDH-mutant diffuse gliomas

甲基硫代腺苷磷酸化酶免疫组化作为成人型IDH突变型弥漫性胶质瘤中CDKN2A纯合缺失替代生物标志物的可靠性评估

Gundogdu, Fatma; Babaoglu, Berrin; Soylemezoglu, Figen

A Case of Nasal Glial Heterotopia That Can Be Misdiagnosed as Storiform Patterned Sclerotic Fibroma/Collagenoma

一例可能被误诊为席纹状硬化性纤维瘤/胶原瘤的鼻神经胶质异位症病例报告

Gundogdu, Fatma; Ozdemir, Deniz Ates; Vargel, Ibrahim

Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer.

靶向赖氨酰氧化酶(LOX)可克服三阴性乳腺癌的化疗耐药性

Saatci Ozge, Kaymak Aysegul, Raza Umar, Ersan Pelin G, Akbulut Ozge, Banister Carolyn E, Sikirzhytski Vitali, Tokat Unal Metin, Aykut Gamze, Ansari Suhail A, Dogan Hayriye Tatli, Dogan Mehmet, Jandaghi Pouria, Isik Aynur, Gundogdu Fatma, Kosemehmetoglu Kemal, Dizdar Omer, Aksoy Sercan, Akyol Aytekin, Uner Aysegul, Buckhaults Phillip J, Riazalhosseini Yasser, Sahin Ozgur

Rapid-infusion rituximab in lymphoma treatment: 2-year experience in a single institution

快速输注利妥昔单抗治疗淋巴瘤:单中心两年经验

Atay, Sevcan; Barista, Ibrahim; Gundogdu, Fatma; Akgedik, Kiymet; Arpaci, Afey